Projects funded by the NCN
Biased inverse agonists of 5-HT6 receptor and dual 5-HT6/MAO-B inhibitors - in search for new therapeutic approaches for the treatment of Alzheimer's disease
2016/21/B/NZ7/01742
Keywords:
biased inverse agonists of 5-HT6 receptor MAO-B inhibitors dual 5-HT6/MAO-B inhibitors dementia cognitive disorders Alzheimer disease mice model of AD
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 14
Call: OPUS 11 - announced on 2016-03-15
Amount awarded: 1 337 400 PLN
Project start date (Y-m-d): 2017-01-24
Project end date (Y-m-d): 2021-12-23
Project duration:: 59 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.